168 related articles for article (PubMed ID: 3924533)
1. Reduction of aspirin-induced fecal blood loss with low-dose misoprostol tablets in man.
Cohen MM; Clark L; Armstrong L; D'Souza J
Dig Dis Sci; 1985 Jul; 30(7):605-11. PubMed ID: 3924533
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, placebo-controlled, 6-day evaluation of two doses of misoprostol in gastroduodenal mucosal protection against damage from aspirin and effect on bowel habits.
Lanza FL; Kochman RL; Geis GS; Rack EM; Deysach LG
Am J Gastroenterol; 1991 Dec; 86(12):1743-8. PubMed ID: 1962619
[TBL] [Abstract][Full Text] [Related]
3. Role of misoprostol in reducing aspirin-induced gastrointestinal blood loss in arthritic patients.
Ryan JR; Vargas R; Clay GA; McMahon FG
Am J Med; 1987 Jul; 83(1A):41-6. PubMed ID: 3113245
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal cytoprotective effects of misoprostol. Clinical efficacy overview.
Dajani EZ; Nissen CH
Dig Dis Sci; 1985 Nov; 30(11 Suppl):194S-200S. PubMed ID: 3932054
[TBL] [Abstract][Full Text] [Related]
5. Effect of synthetic prostaglandin E1 analog on aspirin-induced gastric bleeding and secretion.
Hunt JN; Smith JL; Jiang CL; Kessler L
Dig Dis Sci; 1983 Oct; 28(10):897-902. PubMed ID: 6604619
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 tablets prevent aspirin-induced blood loss in man.
Yik KY; Dreidger AA; Watson WC
Dig Dis Sci; 1982 Nov; 27(11):972-5. PubMed ID: 6982803
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of low dose of enprostil against gastric blood loss induced by aspirin in man.
Thiefin G; Fierfort E; Duchateau A; Garbe E; Joubert M; Zeitoun P
Scand J Gastroenterol; 1989 Sep; 24(7):827-32. PubMed ID: 2508213
[TBL] [Abstract][Full Text] [Related]
8. Reduction by enprostil of aspirin-induced blood loss from human gastric mucosa.
Hawkey CJ; Simpson G; Somerville KW
Am J Med; 1986 Aug; 81(2A):50-3. PubMed ID: 3092655
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of misoprostol in controlling indomethacin induced fecal blood loss in arthritic patients.
Jallad NS; Cattan A; Weidler DJ
Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):376-81. PubMed ID: 8225682
[TBL] [Abstract][Full Text] [Related]
10. Prevention of aspirin-induced fecal blood loss with oral prostaglandin E2: dose-response studies in man.
Cohen MM
Prostaglandins; 1981; 21 Suppl():155-60. PubMed ID: 7029648
[TBL] [Abstract][Full Text] [Related]
11. Misoprostol reduces gastroduodenal injury from one week of aspirin: an endoscopic study.
Jiranek GC; Kimmey MB; Saunders DR; Willson RA; Shanahan W; Silverstein FE
Gastroenterology; 1989 Feb; 96(2 Pt 2 Suppl):656-61. PubMed ID: 2491827
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of nocturnal gastric secretion in normal human volunteers by misoprostol: a synthetic prostaglandin E1 methyl ester analog.
Akdamar K; Agrawal N; Ertan A
Am J Gastroenterol; 1982 Dec; 77(12):902-4. PubMed ID: 6816064
[TBL] [Abstract][Full Text] [Related]
13. Acetylsalicylic acid-induced gastrointestinal bleeding determined by a 51Cr method on a day-to-day basis.
Dybdahl JH; Daae LN; Larsen S; Ekeli H; Frislid K; Wiik I; Aanstad L
Scand J Gastroenterol; 1980; 15(7):887-95. PubMed ID: 6970979
[TBL] [Abstract][Full Text] [Related]
14. Comparative gastrointestinal blood loss associated with placebo, aspirin, and nabumetone as assessed by radiochromium (51Cr).
Lussier A; Davis A; Lussier Y; Lebel E
J Clin Pharmacol; 1989 Mar; 29(3):225-9. PubMed ID: 2786009
[TBL] [Abstract][Full Text] [Related]
15. Comparison of fecal blood loss after use of aspirin and suprofen.
Arnold JD; Berger AE
Pharmacology; 1983; 27 Suppl 1():14-22. PubMed ID: 6606810
[TBL] [Abstract][Full Text] [Related]
16. Prevention of aspirin-induced faecal blood loss by prostaglandin E2.
Cohen MM; Cheung G; Lyster DM
Gut; 1980 Jul; 21(7):602-6. PubMed ID: 7000631
[TBL] [Abstract][Full Text] [Related]
17. A double-blind placebo-controlled comparison of the efficacy and safety of 50, 100, and 200 micrograms of misoprostol QID in the prevention of ibuprofen-induced gastric and duodenal mucosal lesions and symptoms.
Lanza FL; Fakouhi D; Rubin A; Davis RE; Rack MF; Nissen C; Geis S
Am J Gastroenterol; 1989 Jun; 84(6):633-6. PubMed ID: 2499187
[TBL] [Abstract][Full Text] [Related]
18. The use of a synthetic prostaglandin E1 analog as a gastric protectant against aspirin-induced hemorrhage in the dog.
Bowersox TS; Lipowitz AJ; Hardy RM; Johnston GR; Hayden DW; Schwartz S; King VL
J Am Anim Hosp Assoc; 1996; 32(5):401-7. PubMed ID: 8875355
[TBL] [Abstract][Full Text] [Related]
19. Use of synthetic prostaglandin E1 (misoprostol) for prevention of aspirin-induced gastroduodenal ulceration in arthritic dogs.
Murtaugh RJ; Matz ME; Labato MA; Boudrieau RJ
J Am Vet Med Assoc; 1993 Jan; 202(2):251-6. PubMed ID: 8428830
[TBL] [Abstract][Full Text] [Related]
20. Prevention of acute aspirin-induced gastric mucosal injury by 15-R-15 methyl prostaglandin E2: an endoscopic study.
Gilbert DA; Surawicz CM; Silverstein FE; Weinberg CR; Saunders DR; Feld AD; Sanford RL; Bergman D; Washington P
Gastroenterology; 1984 Feb; 86(2):339-45. PubMed ID: 6360786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
